BioLineRx Announces Positive Preclinical Results for Novel Treatment for Chronic Myeloid Leukemia

BKT-140/BL-8040 study published in Molecular Cancer Therapeutics.

BKT-140/BL-8040 is currently undergoing a Phase 2 trial for acute myeloid leukemia (AML) and is expected to commence a Phase 1 trial in stem cell mobilization in Q2 2014; top-line results from both trials are expected in Q4 2014.